Valuation: Virbac

Market Cap 2.72B 3.11B 2.51B 2.33B 4.42B 297B 4.48B 30.02B 11.68B 146B 11.68B 11.42B 505B P/E 2026 *
16.2x
P/E 2027 * 14.4x
Enterprise Value 2.84B 3.25B 2.62B 2.43B 4.62B 310B 4.68B 31.35B 12.2B 152B 12.19B 11.93B 527B EV / Sales 2026 *
1.84x
EV / Sales 2027 * 1.68x
Free-Float
49.03%
Yield 2026 *
0.54%
Yield 2027 * 0.63%
1 day+0.46%
1 week-1.80%
Current month-1.80%
1 month-6.04%
3 months-6.04%
6 months-9.05%
Current year-8.67%
1 week 325
Extreme 325
335
1 month 325
Extreme 325
354
Current year 325
Extreme 325
389.5
1 year 296
Extreme 296
389.5
3 years 239
Extreme 239
400
5 years 215
Extreme 215
448.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 46 2025-08-31
Chief Executive Officer 50 2024-09-26
Chief Operating Officer 64 2021-12-31
Director TitleAgeSince
Chairman 61 2006-03-31
Director/Board Member 68 2010-07-27
Director/Board Member 65 2017-09-04
Date Insider Type Main position Quantity % Market Cap.
24-04-21Sell

Chief Executive Officer

810 0.0096%
24-04-21Sell

Chief Executive Officer

140 0.0017%
24-04-21Sell

Chief Executive Officer

370 0.0044%
Change 5-day change 1-year change 3-year change Capi.($)
+0.46%-1.80%-1.66%+30.60% 3.11B
+0.83%+2.96%-52.62%-55.23% 31.62B
+0.52%+1.58%+71.65%+156.17% 12.55B
-0.47%+6.04%-12.82%+4.98% 3.82B
+3.49%+7.51%+57.87%+33.96% 2.05B
-0.41%+3.94%-27.32%+19.02% 1.66B
+2.62%+7.29%+21.89%+134.89% 1.38B
+1.65%+7.60%-18.91%-8.00% 1.07B
+1.54%+2.54%-2.81%-17.10% 950M
+1.28%+4.28%-13.52%-46.17% 951M
Average +1.20%+4.38%+2.17%+25.31% 5.92B
Weighted average by Cap. +0.46%+3.03%-12.69%+9.25%

Financials

2026 *2027 *
Net sales 1.55B 1.77B 1.42B 1.32B 2.51B 168B 2.54B 17.05B 6.64B 82.67B 6.63B 6.49B 287B 1.64B 1.87B 1.51B 1.4B 2.66B 179B 2.7B 18.08B 7.03B 87.65B 7.03B 6.88B 304B
Net income 167M 191M 154M 143M 271M 18.19B 275M 1.84B 717M 8.93B 716M 700M 30.96B 190M 217M 175M 163M 309M 20.72B 313M 2.1B 816M 10.17B 816M 798M 35.26B
Net Debt 121M 138M 111M 103M 196M 13.18B 199M 1.33B 519M 6.47B 519M 507M 22.43B 26.49M 30.25M 24.4M 22.65M 43.01M 2.89B 43.59M 292M 114M 1.42B 114M 111M 4.91B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
26-07-07 326.50 +0.46% 1,117
26-07-06 €325.00 -2.11% 2,652
26-07-03 €332.00 +0.15% 3,366
26-07-02 €331.50 +0.45% 6,240
26-07-01 €330.00 -0.75% 5,366
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
325.00EUR
Average target price
412.88EUR
Spread / Average Target
+27.04%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIRP Stock